BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 29155846)

  • 1. Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS.
    Doublier S; Zennaro C; Musante L; Spatola T; Candiano G; Bruschi M; Besso L; Cedrino M; Carraro M; Ghiggeri GM; Camussi G; Lupia E
    PLoS One; 2017; 12(11):e0188045. PubMed ID: 29155846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct effect of plasma permeability factors from patients with idiopatic FSGS on nephrin and podocin expression in human podocytes.
    Doublier S; Musante L; Lupia E; Candiano G; Spatola T; Caridi G; Zennaro C; Carraro M; Ghiggeri GM; Camussi G
    Int J Mol Med; 2005 Jul; 16(1):49-58. PubMed ID: 15942677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrotic urine prevents increased rat glomerular albumin permeability induced by serum from the same patient with idiopathic nephrotic syndrome.
    Carraro M; Zennaro C; Candiano G; Musante L; Bruschi M; Ghiggeri GM; Artero M; Faccini L
    Nephrol Dial Transplant; 2003 Apr; 18(4):689-93. PubMed ID: 12637636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin.
    Bertelli R; Ginevri F; Caridi G; Dagnino M; Sandrini S; Di Duca M; Emma F; Sanna-Cherchi S; Scolari F; Neri TM; Murer L; Massella L; Basile G; Rizzoni G; Perfumo F; Ghiggeri GM
    Am J Kidney Dis; 2003 Jun; 41(6):1314-21. PubMed ID: 12776285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome.
    Carraro M; Caridi G; Bruschi M; Artero M; Bertelli R; Zennaro C; Musante L; Candiano G; Perfumo F; Ghiggeri GM
    J Am Soc Nephrol; 2002 Jul; 13(7):1946-52. PubMed ID: 12089392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podocin and uPAR are good biomarkers in cases of Focal and segmental glomerulosclerosis in pediatric renal biopsies.
    Pereira LHM; da Silva CA; Monteiro MLGDR; Araújo LS; Rocha LP; Reis MBDR; Ramalho FS; Corrêa RRM; Silva MV; Reis MA; Machado JR
    PLoS One; 2019; 14(6):e0217569. PubMed ID: 31188898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
    Agrawal V; Prasad N; Jain M; Pandey R
    Clin Exp Nephrol; 2013 Dec; 17(6):811-8. PubMed ID: 23377573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permeability factors in focal segmental glomerulosclerosis.
    Savin VJ; McCarthy ET; Sharma M
    Semin Nephrol; 2003 Mar; 23(2):147-60. PubMed ID: 12704575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy.
    Morita M; Mii A; Shimizu A; Yasuda F; Shoji J; Masuda Y; Ohashi R; Nagahama K; Kaneko T; Tsuruoka S
    PLoS One; 2015; 10(4):e0116700. PubMed ID: 25875837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunohistochemical analysis of podocytopathy with immature glomeruli and glomerulosclerosis in children with nephrotic syndrome].
    Ostalska-Nowicka D; Zachwieja J; Nowicki M; Siwińska A; Woźniak A
    Przegl Lek; 2006; 63 Suppl 3():97-100. PubMed ID: 16898501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular Transcriptome Profiles in Focal Glomerulosclerosis: New Genes and Pathways for Steroid Resistance.
    Tong J; Jin Y; Weng Q; Yu S; Jafar Hussain HM; Ren H; Xu J; Zhang W; Li X; Wang W; Xie J; Chen N
    Am J Nephrol; 2020; 51(6):442-452. PubMed ID: 32348995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplantation.
    Shoji J; Mii A; Terasaki M; Shimizu A
    Nephron; 2020; 144 Suppl 1():65-70. PubMed ID: 33260184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in podocyte TRPC channels evoked by plasma and sera from patients with recurrent FSGS and by putative glomerular permeability factors.
    Kim EY; Roshanravan H; Dryer SE
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2342-2354. PubMed ID: 28629718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPK mediates regulation of glomerular volume and podocyte survival.
    Banu K; Lin Q; Basgen JM; Planoutene M; Wei C; Reghuvaran AC; Tian X; Shi H; Garzon F; Garzia A; Chun N; Cumpelik A; Santeusanio AD; Zhang W; Das B; Salem F; Li L; Ishibe S; Cantley LG; Kaufman L; Lemley KV; Ni Z; He JC; Murphy B; Menon MC
    JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34473647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of proteinase inhibitors on glomerular albumin permeability induced in vitro by serum from patients with idiopathic focal segmental glomerulosclerosis.
    Carraro M; Zennaro C; Artero M; Candiano G; Ghiggeri GM; Musante L; Sirch C; Bruschi M; Faccini L
    Nephrol Dial Transplant; 2004 Aug; 19(8):1969-75. PubMed ID: 15187198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome.
    Doublier S; Ruotsalainen V; Salvidio G; Lupia E; Biancone L; Conaldi PG; Reponen P; Tryggvason K; Camussi G
    Am J Pathol; 2001 May; 158(5):1723-31. PubMed ID: 11337370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis.
    Savin VJ; Sharma R; Sharma M; McCarthy ET; Swan SK; Ellis E; Lovell H; Warady B; Gunwar S; Chonko AM; Artero M; Vincenti F
    N Engl J Med; 1996 Apr; 334(14):878-83. PubMed ID: 8596570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.
    Bruschi M; Catarsi P; Candiano G; Rastaldi MP; Musante L; Scolari F; Artero M; Carraro M; Carrea A; Caridi G; Zennaro C; Sanna-Cherchi S; Viola FB; Ferrario F; Perfumo F; Ghiggeri GM
    Kidney Int; 2003 Feb; 63(2):686-95. PubMed ID: 12631135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic apheresis in idiopathic nephrotic syndrome].
    Moriconi L
    G Ital Nefrol; 2012; 29 Suppl 54():S67-72. PubMed ID: 22388834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy.
    Yang Y; Gubler MC; Beaufils H
    Nephron; 2002 Jul; 91(3):416-23. PubMed ID: 12119471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.